$244.76 0.6%
RMD Stock Price vs. AI Score
Data gathered: May 29

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

AI Stock Analysis - Resmed (RMD)

Analysis generated March 20, 2025. Powered by Chat GPT.

Resmed, an internationally renowned player in the health care sector, specializes in innovative respiratory care solutions. The company's product portfolio includes devices and software solutions for diagnosing, treating, and managing sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed's consistent thrust on R&D has enabled it to develop advanced products that improve patients' lives and reduce healthcare costs. Headquartered in San Diego, California, Resmed operates in over 140 countries.

Read full AI stock Analysis

Stock Alerts - Resmed (RMD)

company logo Resmed | May 28
Insider Alert: Sandercock Brett is selling shares
company logo Resmed | May 23
Insider Alert: De Witte Jan is selling shares
company logo Resmed | May 14
Kelly Morrison (member of U.S. congress) is selling shares
company logo Resmed | May 10
Insider Alert: Farrell Michael J. is selling shares

Download our app to get future alerts delivered in real-time.

About Resmed

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets.


Resmed
Price $244.76
Target Price Sign up
Volume 649,050
Market Cap $36.1B
Year Range $204.1 - $256.52
Dividend Yield 0.87%
PE Ratio 27.24
Analyst Rating 50% buy
Industry Medical Devices

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '251.29B525M766M365M426M2.370
Q4 '241.28B531M751M345M362M2.430
Q3 '241.22B507M717M311M443M2.200
Q2 '241.22B519M704M292M422M2.080
Q1 '241.2B515M682M300M429M2.130

Insider Transactions View All

Sandercock Brett filed to sell 86,283 shares at $244.6.
May 27 '25
De Witte Jan filed to sell 5,806 shares at $243.5.
May 22 '25
FARRELL PETER C filed to sell 71,218 shares at $242.3.
May 8 '25
Farrell Michael J. filed to sell 455,503 shares at $243.2.
May 9 '25
Sandercock Brett filed to sell 89,864 shares at $215.6.
April 10 '25

Congress Trading View All

Politician Filing Date Type Size
Kelly Morrison
May 14, 25 Sell $1K - $15K
Ro Khanna
Dec 6, 24 Buy $1K - $15K
Thomas Tuberville
Republican
Nov 16, 23 Buy $1K - $15K

What is the Market Cap of Resmed?

The Market Cap of Resmed is $36.1B.

What is Resmed's PE Ratio?

As of today, Resmed's PE (Price to Earnings) ratio is 27.24.

What is the current stock price of Resmed?

Currently, the price of one share of Resmed stock is $244.76.

How can I analyze the RMD stock price chart for investment decisions?

The RMD stock price chart above provides a comprehensive visual representation of Resmed's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Resmed shares. Our platform offers an up-to-date RMD stock price chart, along with technical data analysis and alternative data insights.

Does RMD offer dividends to its shareholders?

Yes, Resmed (RMD) offers dividends to its shareholders, with a dividend yield of 0.87%. This dividend yield represents Resmed's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Resmed in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.

What are some of the similar stocks of Resmed?

Some of the similar stocks of Resmed are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2025 AltIndex. All rights reserved.

Chat with AltIndex AI

👋 Welcome to AltIndex AI Chat!

Ask about:
  • Stock performance
  • AI score insights
  • Trending investment opportunities
  • How to use AltIndex
Start typing below to begin.
Disclaimer: AI outputs may be incorrect. This is for informational purposes only and not a substitute for professional financial advice.